European Radiology

, Volume 27, Issue 6, pp 2554–2562 | Cite as

Diffusion-weighted MR enterography for evaluating Crohn’s disease: Effect of anti-peristaltic agent on the diagnosis of bowel inflammation

  • So Hyun Park
  • Jimi Huh
  • Seong Ho Park
  • Seung Soo Lee
  • Ah Young Kim
  • Suk-Kyun Yang



To prospectively investigate how Buscopan affects the diagnosis of bowel inflammation by diffusion-weighted imaging MR enterography (DWI-MRE) in Crohn’s disease (CD).


Thirty CD patients without previous bowel surgery underwent DWI-MRE (b = 900 sec/mm2) before and after intravenous Buscopan. The 30 patients were randomly divided into two groups; using a crossover design, interpretations were made regarding the presence of restricted mural diffusion (i.e., bowel inflammation) in nine bowel segments in two separate reading sessions by two readers. The readers also judged restricted mural diffusion extent in each bowel segment on two side-by-side DWI-MRE images with a random right-to-left order. Ileocolonoscopy and conventional MRE interpreted by an expert panel were reference standards.


We analyzed 262 bowel segments. DWI-MRE without Buscopan significantly decreased sensitivity for both readers (58.8 % vs. 72.9 %, P = 0.046; 57.6 % vs. 85.9 %, P = 0.001) and did not significantly increase specificity (P = 0.085 and 0.396). Two readers noted that 28.6 % and 23.3 % of 262 bowel segments had greater diffusion restriction extent on DWI-MRE with Buscopan compared with DWI-MRE without Buscopan (P < 0.001) and 68.7 % and 74 %, respectively, had similar extent between them.


Omitting Buscopan caused a greater loss in sensitivity of DWI-MRE than false-positive reduction for diagnosing bowel inflammation in CD.

Key Points

Omitting Buscopan significantly decreases DWI-MRE sensitivity for diagnosing bowel inflammation in CD.

Increase in the corresponding DWI-MRE specificity by omitting Buscopan is less apparent.

DWI-MRE without Buscopan underestimates the extent of bowel inflammation in CD.

Keywords (MeSH)

Crohn disease Diffusion Magnetic Resonance Imaging Magnetic Resonance Imaging Butylscopolammonium Bromide Parasympatholytics 



diffusion-weighted imaging


MR enterography


Crohn’s disease


apparent diffusion coefficient


Crohn’s disease activity index



The scientific guarantor of this publication is Dr. Seong Ho Park. The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article. The authors state that this work has not received any funding. Seong Ho Park, MD, PhD, who is one of the authors, has significant statistical expertise and provided statistical advice for this manuscript. Institutional Review Board of Asan Medical Center approval was obtained. Written informed consent was obtained from all subjects (patients) in this study. No study subjects or cohorts have been previously reported. Methodology: prospective, diagnostic or prognostic study, performed at one institution.

Supplementary material

330_2016_4609_MOESM1_ESM.docx (19 kb)
Appendix Table 1 (DOCX 18 kb)
330_2016_4609_MOESM2_ESM.docx (17 kb)
Appendix Table 2 (DOCX 17 kb)


  1. 1.
    Park SH (2016) DWI at MR Enterography for Evaluating Bowel Inflammation in Crohn Disease. AJR Am J Roentgenol 207:40–48CrossRefPubMedGoogle Scholar
  2. 2.
    Choi SH, Kim KW, Lee JY, Kim KJ, Park SH (2016) Diffusion-weighted Magnetic Resonance Enterography for Evaluating Bowel Inflammation in Crohn's Disease: A Systematic Review and Meta-analysis. Inflamm Bowel Dis 22:669–679CrossRefPubMedGoogle Scholar
  3. 3.
    Tielbeek JA, Ziech ML, Li Z et al (2014) Evaluation of conventional, dynamic contrast enhanced and diffusion weighted MRI for quantitative Crohn's disease assessment with histopathology of surgical specimens. Eur Radiol 24:619–629CrossRefPubMedGoogle Scholar
  4. 4.
    Catalano OA, Gee MS, Nicolai E et al (2015) Evaluation of Quantitative PET/MR Enterography Biomarkers for Discrimination of Inflammatory Strictures from Fibrotic Strictures in Crohn Disease. Radiology 278:792–800CrossRefPubMedGoogle Scholar
  5. 5.
    Kovanlikaya A, Beneck D, Rose M et al (2015) Quantitative apparent diffusion coefficient (ADC) values as an imaging biomarker for fibrosis in pediatric Crohn's disease: preliminary experience. Abdom Imaging 40:1068–1074CrossRefPubMedGoogle Scholar
  6. 6.
    Seo N, Park SH, Kim KJ et al (2016) MR Enterography for the Evaluation of Small-Bowel Inflammation in Crohn Disease by Using Diffusion-weighted Imaging without Intravenous Contrast Material: A Prospective Noninferiority Study. Radiology 278:762–772CrossRefPubMedGoogle Scholar
  7. 7.
    Grand DJ, Beland MD, Machan JT, Mayo-Smith WW (2012) Detection of Crohn's disease: Comparison of CT and MR enterography without anti-peristaltic agents performed on the same day. Eur J Radiol 81:1735–1741CrossRefPubMedGoogle Scholar
  8. 8.
    Grand DJ, Kampalath V, Harris A et al (2012) MR enterography correlates highly with colonoscopy and histology for both distal ileal and colonic Crohn's disease in 310 patients. Eur J Radiol 81:e763–e769CrossRefPubMedGoogle Scholar
  9. 9.
    Grand DJ, Guglielmo FF, Al-Hawary MM (2015) MR enterography in Crohn's disease: current consensus on optimal imaging technique and future advances from the SAR Crohn's disease-focused panel. Abdom Imaging 40:953–964CrossRefPubMedGoogle Scholar
  10. 10.
    Smolinski S, George M, Dredar A, Hayes C, Rakita D (2014) Magnetic resonance enterography in evaluation and management of children with Crohn's disease. Semin Ultrasound CT MR 35:331–348CrossRefPubMedGoogle Scholar
  11. 11.
    Bickelhaupt S, Pazahr S, Chuck N et al (2013) Crohn's disease: small bowel motility impairment correlates with inflammatory-related markers C-reactive protein and calprotectin. Neurogastroenterol Motil 25:467–473CrossRefPubMedGoogle Scholar
  12. 12.
    Cullmann JL, Bickelhaupt S, Froehlich JM et al (2013) MR imaging in Crohn's disease: correlation of MR motility measurement with histopathology in the terminal ileum. Neurogastroenterol Motil 25:749–e577CrossRefPubMedGoogle Scholar
  13. 13.
    Menys A, Atkinson D, Odille F et al (2012) Quantified terminal ileal motility during MR enterography as a potential biomarker of Crohn's disease activity: a preliminary study. Eur Radiol 22:2494–2501CrossRefPubMedGoogle Scholar
  14. 14.
    Bickelhaupt S, Froehlich JM, Cattin R et al (2013) Differentiation between active and chronic Crohn's disease using MRI small-bowel motility examinations - initial experience. Clin Radiol 68:1247–1253CrossRefPubMedGoogle Scholar
  15. 15.
    Froehlich JM, Waldherr C, Stoupis C, Erturk SM, Patak MA (2010) MR motility imaging in Crohn's disease improves lesion detection compared with standard MR imaging. Eur Radiol 20:1945–1951CrossRefPubMedGoogle Scholar
  16. 16.
    Kim KJ, Lee Y, Park SH et al (2015) Diffusion-weighted MR enterography for evaluating Crohn's disease: how does it add diagnostically to conventional MR enterography? Inflamm Bowel Dis 21:101–109CrossRefPubMedGoogle Scholar
  17. 17.
    Steward MJ, Punwani S, Proctor I et al (2012) Non-perforating small bowel Crohn's disease assessed by MRI enterography: derivation and histopathological validation of an MR-based activity index. Eur J Radiol 81:2080–2088CrossRefPubMedGoogle Scholar
  18. 18.
    Tielbeek JA, Makanyanga JC, Bipat S et al (2013) Grading Crohn disease activity with MRI: interobserver variability of MRI features, MRI scoring of severity, and correlation with Crohn disease endoscopic index of severity. AJR Am J Roentgenol 201:1220–1228CrossRefPubMedGoogle Scholar
  19. 19.
    Plumb AA, Pendse DA, McCartney S, Punwani S, Halligan S, Taylor SA (2014) Lymphoid nodular hyperplasia of the terminal ileum can mimic active crohn disease on MR enterography. AJR Am J Roentgenol 203:W400–W407CrossRefPubMedGoogle Scholar
  20. 20.
    Dohan A, Taylor S, Hoeffel C et al (2016) Diffusion-weighted MRI in Crohn's disease: Current status and recommendations. J Magn Reson Imaging. doi: 10.1002/jmri.25325 Google Scholar
  21. 21.
    Kiryu S, Dodanuki K, Takao H et al (2009) Free-breathing diffusion-weighted imaging for the assessment of inflammatory activity in Crohn's disease. J Magn Reson Imaging 29:880–886CrossRefPubMedGoogle Scholar
  22. 22.
    Oto A, Zhu F, Kulkarni K, Karczmar GS, Turner JR, Rubin D (2009) Evaluation of diffusion-weighted MR imaging for detection of bowel inflammation in patients with Crohn's disease. Acad Radiol 16:597–603CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Ordas I, Rimola J, Rodriguez S et al (2014) Accuracy of magnetic resonance enterography in assessing response to therapy and mucosal healing in patients with Crohn's disease. Gastroenterology 146:374–382.e1CrossRefPubMedGoogle Scholar
  24. 24.
    Rimola J, Ordas I (2014) MR colonography in inflammatory bowel disease. Magn Reson Imaging Clin N Am 22:23–33CrossRefPubMedGoogle Scholar
  25. 25.
    Rimola J, Rodriguez S, Garcia-Bosch O et al (2009) Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn's disease. Gut 58:1113–1120CrossRefPubMedGoogle Scholar
  26. 26.
    Qiu Y, Mao R, Chen BL et al (2014) Systematic review with meta-analysis: magnetic resonance enterography vs. computed tomography enterography for evaluating disease activity in small bowel Crohn's disease. Aliment Pharmacol Ther 40:134–146CrossRefPubMedGoogle Scholar
  27. 27.
    Church PC, Turner D, Feldman BM et al (2015) Systematic review with meta-analysis: magnetic resonance enterography signs for the detection of inflammation and intestinal damage in Crohn's disease. Aliment Pharmacol Ther 41:153–166CrossRefPubMedGoogle Scholar
  28. 28.
    Menys A, Taylor SA, Emmanuel A et al (2013) Global small bowel motility: assessment with dynamic MR imaging. Radiology 269:443–450CrossRefPubMedGoogle Scholar

Copyright information

© European Society of Radiology 2016

Authors and Affiliations

  1. 1.Department of Radiology and Research Institute of RadiologyUniversity of Ulsan College of Medicine, Asan Medical CenterSongpa-guSouth Korea
  2. 2.Department of Radiology, Gil Medical CenterGachon UniversityIncheonSouth Korea
  3. 3.Department of GastroenterologyUniversity of Ulsan College of Medicine, Asan Medical CenterSongpa-guSouth Korea

Personalised recommendations